tiprankstipranks
BofA moves to No Rating on Sage Therapeutics after Biogen bid
PremiumThe FlyBofA moves to No Rating on Sage Therapeutics after Biogen bid
2d ago
Morning Movers: Intra-Cellular surges following deal to be bought by J&J
Premium
The Fly
Morning Movers: Intra-Cellular surges following deal to be bought by J&J
2d ago
Sage Therapeutics confirms $7.22 per share acquisition proposal from Biogen
Premium
The Fly
Sage Therapeutics confirms $7.22 per share acquisition proposal from Biogen
4d ago
Alphabet, Uber downgraded: Wall Street’s top analyst calls
PremiumThe FlyAlphabet, Uber downgraded: Wall Street’s top analyst calls
13d ago
Biogen downgraded to Neutral from Overweight at Piper Sandler
Premium
The Fly
Biogen downgraded to Neutral from Overweight at Piper Sandler
13d ago
Biogen downgraded to Market Perform from Outperform at BMO Capital
Premium
The Fly
Biogen downgraded to Market Perform from Outperform at BMO Capital
26d ago
Biogen downgraded to Hold from Buy at Jefferies
PremiumThe FlyBiogen downgraded to Hold from Buy at Jefferies
1M ago
GeneDx expands access to exome testing for pediatric epilepsy patients
Premium
The Fly
GeneDx expands access to exome testing for pediatric epilepsy patients
1M ago
Eisai, Biogen say LEQEMBI approved for treatment of early AD in Mexico
Premium
The Fly
Eisai, Biogen say LEQEMBI approved for treatment of early AD in Mexico
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100